0.00Open0.34Pre Close0 Volume5 Open Interest89.00Strike Price0.00Turnover3098.06%IV14.03%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier-5DDays to Expiry0.34Extrinsic Value100Contract SizeAmericanOptions Type0.1111Delta0.0290Gamma230.43Leverage Ratio-241.4665Theta0.0000Rho25.60Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet